Semaglutide is a medication used to treat type 2 diabetes. It is a type of drug known as a glucagon-like peptide-1 (GLP-1) receptor agonist, which works by increasing the amount of insulin released by the pancreas in response to high blood sugar levels.
Semaglutide is taken as a once-weekly injection under the skin. It is typically prescribed to be used in combination with other diabetes medications, such as metformin, to help control blood sugar levels.
One of the key benefits of semaglutide is its ability to lower HbA1c, a measure of blood sugar control over time. Studies have shown that semaglutide can reduce HbA1c levels by up to 1.5% compared to other diabetes medications. Additionally, semaglutide has been shown to help patients lose weight, which can be beneficial for those with obesity-related type 2 diabetes.
Semaglutide is generally well-tolerated, with the most common side effects being mild to moderate nausea, diarrhea, and stomach pain. However, it is not recommended for use in patients with a history of pancreatitis, and should be used with caution in patients with a history of renal impairment.
Overall, semaglutide is an effective option for treating type 2 diabetes, particularly for those who have not been able to achieve adequate blood sugar control with other medications. It can help lower HbA1c levels and promote weight loss, making it a valuable addition to the diabetes treatment arsenal.